These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7260784)

  • 21. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay.
    Manni A; Wright C; Davis G; Glenn J; Joehl R; Feil P
    Cancer Res; 1986 Apr; 46(4 Pt 1):1669-72. PubMed ID: 3948157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroid hormone receptors and their relevance for the therapy of mammary cancers (author's transl)].
    Heise E
    Arch Geschwulstforsch; 1981; 51(8):727-36. PubMed ID: 7041847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,25-dihydroxyvitamin D3 and breast cancer.
    Eisman JA; Suva LJ; Frampton RJ
    Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oestrogen receptors determination in human breast cancer (author's transl)].
    Messeri G; Longo G
    Quad Sclavo Diagn; 1979 Jun; 15(2):196-207. PubMed ID: 554158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid binding properties of estradiol receptors in human breast cancer.
    Jänne O; Kontula K; Vihko R; Pystynen P; Auvinen O; Lauslahti K
    Med Biol; 1975 Aug; 53(4):214-23. PubMed ID: 171527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
    Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estrogen receptors in primary breast neoplasms].
    Tsyrlina EV; Moiseenko VM; Boronoeva TR; Semiglazov VF
    Vopr Onkol; 1984; 30(4):29-33. PubMed ID: 6328757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor in very small breast tumor specimens: a modified charcoal-gelatin assay.
    Tandon AK; Chamness GC; McGuire WL
    Cancer Res; 1986 Jul; 46(7):3375-7. PubMed ID: 3708571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
    Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers.
    Eisman JA; Suva LJ; Martin TJ
    Cancer Res; 1986 Oct; 46(10):5406-8. PubMed ID: 3019526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone-receptor assays in breast cancer. A five-year experience.
    Mercer RJ; Lie TH; Rennie GC; Bennett RC; Morgan FJ
    Med J Aust; 1983 Apr; 1(8):365-9. PubMed ID: 6835143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.